Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anhydrous, Ciprofloxacin Hydrochloride
2. Bay 09867
3. Bay-09867
4. Bay09867
5. Ciprinol
6. Cipro
7. Ciprofloxacin
8. Ciprofloxacin Hydrochloride Anhydrous
9. Ciprofloxacin Monohydrochloride Monohydrate
10. Hydrochloride Anhydrous, Ciprofloxacin
11. Hydrochloride, Ciprofloxacin
12. Monohydrate, Ciprofloxacin Monohydrochloride
13. Monohydrochloride Monohydrate, Ciprofloxacin
1. Ciprofloxacin Hcl
2. 93107-08-5
3. 86483-48-9
4. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
5. Cipro
6. Chebi:310388
7. Ciprofloxacin Hydrochloride Anhydrous
8. 0mp32mfp6c
9. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hydrochloride
10. Ciprofloxacin (monohydrochloride)
11. Bay-o-9867
12. Ciprofloxacin Hydrochloride (anh.)
13. Bay O 9867
14. Cetraxal
15. Ciprobay
16. Ciproxan
17. Ciproxin
18. Flociprin
19. Ciflox
20. Mfcd00079044
21. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hcl
22. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid;hydrochloride
23. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Xhydrochloride
24. Bay-o 9867
25. 93107-08-5 (hcl)
26. 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic Acid Hydrochloride
27. Dsstox_cid_27768
28. Dsstox_rid_82545
29. Dsstox_gsid_47788
30. Ciprofloxacin (as Hydrochloride)
31. Prestwick_67
32. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic Acid; Hydrochloride
33. 4-(3-carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinolin-7-yl)-piperazin-1-ium; Chloride
34. Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride
35. Nsc620634
36. Ciprofloxacin Hydrochloride (anhydrous)
37. Ciprofloxacin 100 Microg/ml In Methanol
38. Ncgc00016959-01
39. Cas-93107-08-5
40. Unii-0mp32mfp6c
41. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride
42. 3-quiolinecarboxylic Acid
43. Ciprofloxacine Hydrochloride
44. Epitope Id:174846
45. Cambridge Id 5807784
46. Ciprofloxacini Hydrochloridum
47. Chembl1202
48. Schembl42310
49. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Monohydrochloride
50. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Monohydrochloride
51. Ciprofloxacin Hcl/lactate
52. Dtxsid1047788
53. Hy-b0356a
54. Ciprofloxacin Hydrochloride (1:x)
55. Hms1568g08
56. Bcp13634
57. Bcp14336
58. Tox21_110712
59. S5008
60. Akos005111008
61. Tox21_110712_1
62. Cs-8134
63. Ks-5012
64. Nsc-620634
65. Sb73037
66. Ncgc00016959-06
67. 3-quinolinecarboxylic Acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, Hydrochloride
68. Ac-23972
69. Bim-0048462.p001
70. Ciprofloxacin 1000 Microg/ml In Methanol
71. Ciprofloxacin Hydrochloride [who-dd]
72. Ft-0623850
73. Ft-0623851
74. A16969
75. H10663
76. A859872
77. Q-200860
78. Q27105154
79. F0001-2378
80. Cpx; Cetraxal; Ciloxan; Cipro; Bay-09867 Hydrochloride
81. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hcl
82. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidxhydrochloride
83. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride (1:1)
| Molecular Weight | 367.8 g/mol |
|---|---|
| Molecular Formula | C17H19ClFN3O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 367.1098973 g/mol |
| Monoisotopic Mass | 367.1098973 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 571 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Ciprofloxacin hydrochloride |
| PubMed Health | Ciprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth) |
| Drug Classes | Antibacterial |
| Drug Label | Ciprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip... |
| Active Ingredient | Ciprofloxacin hydrochloride |
| Dosage Form | Solution/drops; Tablet |
| Route | Ophthalmic; Oral |
| Strength | eq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base |
| Market Status | Prescription |
| Company | Watson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn |
| 2 of 2 | |
|---|---|
| Drug Name | Ciprofloxacin hydrochloride |
| PubMed Health | Ciprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth) |
| Drug Classes | Antibacterial |
| Drug Label | Ciprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip... |
| Active Ingredient | Ciprofloxacin hydrochloride |
| Dosage Form | Solution/drops; Tablet |
| Route | Ophthalmic; Oral |
| Strength | eq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base |
| Market Status | Prescription |
| Company | Watson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn |
Treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Cytochrome P-450 CYP1A2 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Neuland Laboratories- A dedicated 100% API provider.
GDUFA
DMF Review : Complete
Rev. Date : 2012-10-26
Pay. Date : 2012-12-13
DMF Number : 13250
Submission : 1998-09-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8134
Submission : 1989-07-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8627
Submission : 1990-07-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14709
Submission : 2000-02-11
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-10-14
Pay. Date : 2015-10-05
DMF Number : 11966
Submission : 1996-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8517
Submission : 1990-04-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13072
Submission : 1998-07-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14474
Submission : 1999-10-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16544
Submission : 2003-04-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14905
Submission : 2000-05-22
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE
USFDA APPLICATION NUMBER - 19992
DOSAGE - OINTMENT;OPHTHALMIC - EQ 0.3% BASE
USFDA APPLICATION NUMBER - 20369
DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE...DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%
USFDA APPLICATION NUMBER - 20805
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Curia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Disintegrants & Superdisintegrants
Solubilizers
Direct Compression
Thickeners and Stabilizers
Granulation
Controlled & Modified Release
Parenteral
Topical
Taste Masking
Lubricants & Glidants
Film Formers & Plasticizers
Chewable & Orodispersible Aids
Co-Processed Excipients
Emulsifying Agents
API Stability Enhancers
Rheology Modifiers
Surfactant & Foaming Agents
Coloring Agents
Empty Capsules
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Ciprofloxacin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ciprofloxacin Hydrochloride API Price utilized in the formulation of products. Ciprofloxacin Hydrochloride API Price is not always fixed or binding as the Ciprofloxacin Hydrochloride Price is obtained through a variety of data sources. The Ciprofloxacin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ciprofloxacin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprofloxacin HCl, including repackagers and relabelers. The FDA regulates Ciprofloxacin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprofloxacin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ciprofloxacin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ciprofloxacin HCl supplier is an individual or a company that provides Ciprofloxacin HCl active pharmaceutical ingredient (API) or Ciprofloxacin HCl finished formulations upon request. The Ciprofloxacin HCl suppliers may include Ciprofloxacin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Ciprofloxacin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciprofloxacin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciprofloxacin HCl active pharmaceutical ingredient (API) in detail. Different forms of Ciprofloxacin HCl DMFs exist exist since differing nations have different regulations, such as Ciprofloxacin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ciprofloxacin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Ciprofloxacin HCl USDMF includes data on Ciprofloxacin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciprofloxacin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ciprofloxacin HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ciprofloxacin HCl Drug Master File in Japan (Ciprofloxacin HCl JDMF) empowers Ciprofloxacin HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ciprofloxacin HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Ciprofloxacin HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ciprofloxacin HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ciprofloxacin HCl Drug Master File in Korea (Ciprofloxacin HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ciprofloxacin HCl. The MFDS reviews the Ciprofloxacin HCl KDMF as part of the drug registration process and uses the information provided in the Ciprofloxacin HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ciprofloxacin HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ciprofloxacin HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ciprofloxacin HCl suppliers with KDMF on PharmaCompass.
A Ciprofloxacin HCl CEP of the European Pharmacopoeia monograph is often referred to as a Ciprofloxacin HCl Certificate of Suitability (COS). The purpose of a Ciprofloxacin HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ciprofloxacin HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ciprofloxacin HCl to their clients by showing that a Ciprofloxacin HCl CEP has been issued for it. The manufacturer submits a Ciprofloxacin HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ciprofloxacin HCl CEP holder for the record. Additionally, the data presented in the Ciprofloxacin HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ciprofloxacin HCl DMF.
A Ciprofloxacin HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ciprofloxacin HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ciprofloxacin HCl suppliers with CEP (COS) on PharmaCompass.
A Ciprofloxacin HCl written confirmation (Ciprofloxacin HCl WC) is an official document issued by a regulatory agency to a Ciprofloxacin HCl manufacturer, verifying that the manufacturing facility of a Ciprofloxacin HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ciprofloxacin HCl APIs or Ciprofloxacin HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Ciprofloxacin HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Ciprofloxacin HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ciprofloxacin HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ciprofloxacin HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ciprofloxacin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ciprofloxacin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ciprofloxacin HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ciprofloxacin HCl suppliers with NDC on PharmaCompass.
Ciprofloxacin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciprofloxacin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciprofloxacin HCl GMP manufacturer or Ciprofloxacin HCl GMP API supplier for your needs.
A Ciprofloxacin HCl CoA (Certificate of Analysis) is a formal document that attests to Ciprofloxacin HCl's compliance with Ciprofloxacin HCl specifications and serves as a tool for batch-level quality control.
Ciprofloxacin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Ciprofloxacin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciprofloxacin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciprofloxacin HCl EP), Ciprofloxacin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciprofloxacin HCl USP).
